Genomic & Biopharma News

Disease diagnostics take top honors of DEBUT biomedical engineering design competition
NIH and VentureWell support undergraduate biomedical engineering challenge seeking innovative devices to improve health globally.
National Institutes of Health, 2017-08-25 21:30:00

The top 10 cardiovascular drugs in the world
Cardiovascular drugs may not be the top field in terms of sales or market growth rate. But heart disease and related ailments remain the biggest cause of death in the U.S. We’ve put together this list in advance of this weekend’s European Society of Cardiology meeting in Barcelona as a state-of-the-market snapshot.
Fierce Pharma, 2017-08-25 19:00:30

The top companies in medtech by 2016 revenue
2016 was the year of the makeover. The top 10 medtech players are all in varying stages of transformation. Some companies, like Philips and Siemens, are well into their metamorphoses, while others, such as Boston Scientific and Johnson & Johnson, made moves to overhaul their medtech businesses.
Fierce Biotech, 2017-08-25 18:50:06

Robotic exoskeleton offers potential new approach to alleviating crouch gait in children with cerebral palsy
This study is the first step toward the long-term goal of implementing a novel device-based approach to treating crouch gait.
National Institutes of Health, 2017-08-25 18:15:00

Labs in Texas Batten Down the Hatches
As Hurricane Harvey approaches land, researchers wait to see if their preparations will protect their experiments.
The Scientist, 2017-08-25 16:00:00

Insights into fat signaling could boost the fight against obesity and diabetes
Natriuretic peptides, or NPs, send signals in adipose tissue that can turn harmful white fat into energy-burning brown fat. But NP signaling may have an even broader role in protecting against metabolic disease.
Fierce Biotech, 2017-08-25 15:38:37

Adamas scores orphan approval for tweaked generic Parkinson's medication
Adamas may be the first company to have won FDA approval for a medication to treat dyskinesia in Parkinson’s patients. But that doesn’t mean it will be the first company to use that med to treat the condition.
Fierce Pharma, 2017-08-25 15:37:10

News of Note—Cancer diagnostics startup Celcuity files for $15M IPO
Here's Friday's medtech news of note.
Fierce Biotech, 2017-08-25 15:34:28

Exosome Diagnostics, CareFirst partner to speed up coverage for diagnostic tests
Liquid biopsy player Exosome Diagnostics is partnering with CareFirst to create evidence development studies for the evaluation of its EvoDx tests.
Fierce Biotech, 2017-08-25 15:08:46